Z-501

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameZ-501
Drug Alias Nameneurokinin NK2 receptor antagonist (Zeria)Z-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 2 receptor antagonists
TargetsNeurokinin 2 receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZeria Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZeria Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A